Publisher： Bentham Science Publishers
E-ISSN： 1875-5631|8|4|236-246
ISSN： 1566-5232
Source： Current Gene Therapy, Vol.8, Iss.4, 2008-08, pp. : 236-246
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Since the RNAi mechanisms were established in 1990, the rapid progression of RNAi application from animal to clinical trails in human diseases has shown its enormous therapeutic potential. In this review, RNAi therapeutics in allergic diseases is discussed, from RNAi mechanisms and design to challenges and potential targets in allergic diseases. Current reported studies on investigating RNAi therapy in vitro and in vivo are also reviewed. Although there are promising studies in RNAi-based therapy, understanding further the detailed mechanisms of RNAi-based therapy and investigating more effective delivery methods are required for future development.
Related content
Access to resources
Recommend
Budding Alliance of Nanotechnology in RNA Interference Therapeutics
Current Pharmaceutical Design, Vol. 24, Iss. 23, 2018-06 ,pp. :
New Strategies and Patent Therapeutics in EBV-Associated Diseases
Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 10, 2010-09 ,pp. :